Media ReleasesOventus Medical

View All Oventus Medical News


Oventus Announce Further Material Agreements with two US Sleep Groups

Oventus signs further material agreements with two US sleep groups to deliver O2Vent® Sleep Treatment Platform to patients with sleep apnoea

Key points:

  • Agreements signed with US sleep groups, Delaware Sleep Disorder Centres and Reliable Respiratory, to supply dental sleep medicine solutions across a total of 10 facilities
  • Adds to news of first agreements signed in June and July with sleep groups in Canada and the US for the Oventus O2Vent® Sleep Treatment Platform which treats obstructive sleep apnoea (OSA)
  • Oventus expects to secure further agreements across its key target markets in the US, Canada and Australia over the next 12-24 months, with a view to significant scaling through to the end of CY2019 and CY2020; negotiations ongoing with multiple groups
  • Oventus is strongly positioned to scale sales substantially following the announcement of a capital raise on 26 July: Placement of A$7m and Entitlement Offer launched to raise A$2.3m from existing shareholders
For further information please download the attached PDF: Download this document